Losartan recall - Legacy Pharmaceuticals

30 de abril del 2019

Express Scripts did NOT dispense any lots impacted by this recall.

On April 25th 2019, Legacy Pharmaceuticals announced an expansion of their recall of Losartan 50mg Tablets to a total of 4 lots due to the detection of an unexpected impurity found in the active pharmaceutical ingredient manufactured by Hetero Labs Limited.

Additional information is available on the FDA's website:


Última actualización: 13 de marzo del 2020